thioflavin t has been researched along with Tauopathies in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (60.00) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Bastone, A; Cantù, L; Cimini, S; Colombo, L; De Luigi, A; Del Favero, E; Ricci, C; Rossi, G; Russo, L; Salmona, M; Tagliavini, F | 1 |
Kasho, K; Krasauskas, L; Morozova-Roche, LA; Smirnovas, V; Stojkovič, G; Wanrooij, S | 1 |
Callaway, K; Dobson, CM; Mandelkow, E; Mandelkow, EM; McConlogue, L; Neumann, T; Pickhardt, M; Schenk, D; Schwizer, D; St George-Hyslop, P; Tóth, G; Vendruscolo, M | 1 |
Bulic, B; Mandelkow, E; Mandelkow, EM; Pickhardt, M; Schmidt, B; Waldmann, H | 1 |
Cassell, MD; Ding, SL; Poremba, A; Van Hoesen, GW | 1 |
Haddix, T; Lee, VM; Nakashima-Yasuda, H; Robinson, J; Trojanowski, JQ; Uryu, K | 1 |
Bresjanac, M; Kovacs, GG; Mohorko, N; Popović, M; Repovs, G | 1 |
Hayashi, S; Ihara, M; Kimura, H; Matsumura, K; Mori, H; Okamoto, Y; Ono, M; Saji, H; Takahashi, R | 1 |
Bellmann, C; Giasson, BI; Horiguchi, T; Ischiropoulos, H; Lee, VM; LightFoot, R; Richter-Landsberg, C; Trojanowski, JQ; Uryu, K | 1 |
Dabir, D; Forman, MS; Goldbaum, O; Handschuh, M; Lee, VM; Oppermann, M; Richter-Landsberg, C; Trojanowski, JQ; Zhang, B | 1 |
Chirita, CN; Kuret, J; Necula, M | 1 |
Champy, P; Duyckaerts, C; Féger, J; Hirsch, EC; Höglinger, GU; Khondiker, ME; Lannuzel, A; Lombes, A; Medja, F; Michel, PP; Oertel, WH; Prigent, A; Ruberg, M | 1 |
Biernat, J; Gazova, Z; Khlistunova, I; Mandelkow, E; Mandelkow, EM; Pickhardt, M; von Bergen, M; Wang, Y | 1 |
Arnold, SE; Chatterjee, A; Clark, CM; Coslett, HB; Farmer, J; Forman, MS; Grossman, M; Hurtig, HI; Johnson, JK; Karlawish, JH; Lee, VM; Miller, BL; Rosen, HJ; Trojanowski, JQ; Van Deerlin, V | 1 |
Coksezen, A; Khlistunova, I; Larbig, G; Mandelkow, E; Mandelkow, EM; Meyer, B; Pickhardt, M; Schmidt, B | 1 |
1 review(s) available for thioflavin t and Tauopathies
Article | Year |
---|---|
Development of tau aggregation inhibitors for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzothiazoles; Databases, Factual; Humans; tau Proteins; Tauopathies; Thiazoles | 2009 |
14 other study(ies) available for thioflavin t and Tauopathies
Article | Year |
---|---|
Biochemical and biophysical features of disease-associated tau mutants V363A and V363I.
Topics: Benzothiazoles; Brain; Heparin; Humans; Molecular Structure; Mutation; Oligonucleotides; Protein Aggregates; Protein Conformation; Scattering, Small Angle; tau Proteins; Tauopathies | 2022 |
Human Polymerase δ-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzothiazoles; Brain; Humans; Nuclear Proteins; tau Proteins; Tauopathies | 2021 |
Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies.
Topics: Animals; Benzothiazoles; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluorescent Dyes; High-Throughput Screening Assays; Humans; Mice; Microarray Analysis; Microscopy, Fluorescence; Molecular Structure; Neuroprotective Agents; Protein Aggregates; Protein Multimerization; tau Proteins; Tauopathies; Thiazoles | 2015 |
Parcellation of human temporal polar cortex: a combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antigens, Nuclear; Benzothiazoles; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Nerve Tissue Proteins; Plant Lectins; Pyramidal Cells; Receptors, N-Acetylglucosamine; Tauopathies; Temporal Lobe; Thiazoles | 2009 |
Burden of neurodegenerative diseases in a cohort of medical examiner subjects.
Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Atrophy; Benzothiazoles; Brain; Brain Edema; Cohort Studies; Coroners and Medical Examiners; Female; Forensic Pathology; Frontotemporal Lobar Degeneration; Humans; Hygiene; Ill-Housed Persons; Immunohistochemistry; Male; Malnutrition; Middle Aged; Neurofibrillary Tangles; Neuropil Threads; Plaque, Amyloid; Staining and Labeling; Tauopathies; Thiazoles; Young Adult | 2010 |
Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples.
Topics: Alzheimer Disease; Benzothiazoles; Brain Diseases; Curcumin; Humans; Neurofibrillary Tangles; Neurons; Pick Disease of the Brain; Silver Staining; Supranuclear Palsy, Progressive; tau Proteins; Tauopathies; Thiazoles | 2010 |
Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains.
Topics: Alzheimer Disease; Animals; Autoradiography; Benzothiazoles; Brain; Humans; Iodine Radioisotopes; Mice; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Rhodanine; Tauopathies; Thiazoles; Thiohydantoins; Tissue Distribution | 2011 |
Nitration of tau protein is linked to neurodegeneration in tauopathies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Basal Ganglia; Benzothiazoles; Cell Line; Cerebral Cortex; Down Syndrome; Female; Fluorescent Dyes; Humans; Male; Middle Aged; Nerve Degeneration; Neurodegenerative Diseases; Neurofibrillary Tangles; Nitrates; Pick Disease of the Brain; tau Proteins; Tauopathies; Thiazoles; Tissue Distribution | 2003 |
Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid.
Topics: alpha-Crystallin B Chain; Benzothiazoles; Brain; Cell Line; Cysteine Endopeptidases; Cytoskeleton; Enzyme Inhibitors; Fluorescent Dyes; Humans; Immunohistochemistry; Inclusion Bodies; Leupeptins; Microtubules; Multienzyme Complexes; Okadaic Acid; Oligodendroglia; Phosphoprotein Phosphatases; Phosphorylation; Proteasome Endopeptidase Complex; Protein Phosphatase 2; tau Proteins; Tauopathies; Thiazoles | 2003 |
Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.
Topics: Benzothiazoles; Binding, Competitive; Carbocyanines; Humans; Kinetics; Models, Chemical; Nerve Tissue Proteins; Protein Processing, Post-Translational; Solubility; tau Proteins; Tauopathies; Thiazoles | 2005 |
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Benzothiazoles; Body Weight; Caspase 3; Caspases; Cell Death; Cerebral Cortex; Cytarabine; Diagnostic Imaging; Dopamine and cAMP-Regulated Phosphoprotein 32; Doxorubicin; Dystonia; Electron Transport Complex III; Enzyme Activation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Locomotion; Male; Microscopy, Electron, Transmission; Mitochondria; Neurons; Phosphopyruvate Hydratase; Phosphorylation; Posture; Psychomotor Performance; Rats; Rats, Inbred Lew; Rotenone; tau Proteins; Tauopathies; Thiazoles; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase; Ubiquitin; Uncoupling Agents | 2005 |
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
Topics: Alzheimer Disease; Amino Acid Motifs; Benzothiazoles; Brain; Cell Line; Cell Line, Tumor; Centrifugation, Density Gradient; Chromatography; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Gene Deletion; Humans; Mass Spectrometry; Microscopy, Electron; Microscopy, Fluorescence; Models, Biological; Models, Chemical; Mutation; Neurons; Peptide Hydrolases; Phosphorylation; Plasmids; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; tau Proteins; Tauopathies; Thiazoles; Thrombin; Time Factors | 2006 |
Frontotemporal dementia: clinicopathological correlations.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Benzothiazoles; Brain; Dementia; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Inclusion Bodies; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Tauopathies; Thiazoles; Ubiquitin | 2006 |
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
Topics: Animals; Benzothiazoles; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Humans; Hydrazines; Hydro-Lyases; Ligands; Models, Biological; Models, Chemical; Neurofibrillary Tangles; Protein Binding; Protein Denaturation; Protein Structure, Tertiary; tau Proteins; Tauopathies; Thiazoles | 2007 |